UROKINASE-TYPE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS AS GROWTH-FACTORS OF HUMAN FIBROBLASTS

被引:80
作者
DEPETRO, G [1 ]
COPETA, A [1 ]
BARLATI, S [1 ]
机构
[1] UNIV BRESCIA, DEPT BIOMED SCI & BIOTECHNOL, DIV BIOL & GENET, I-25123 BRESCIA, ITALY
关键词
D O I
10.1006/excr.1994.1200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study we have verified the mitogenic effect of urokinase-type (u-PA) and tissue-type plasminogen activators (t-PA) on human normal fibroblasts. We report that both PAs can induce DNA replication and cell division in serum-deprived cultured human skin fibroblasts. The activity of u-PA and t-PA is, respectively, three- and twofold more potent than that exerted by epidermal growth factor (EGF) with an activity slightly lower (50-60%) than that induced by basic fibroblast growth factor (bFGF). The u-PA and t-PA, but not plasmin, induced DNA synthesis, which could be neutralized by anti-u-PA and anti-t-PA antibodies, respectively, but was insensitive to aprotinin treatment. The addition of anti-u-PA-receptor (u-PAR) monoclonal antibodies to the assays selectively suppressed the mitogenic effect exerted by u-PA, but not that of t-PA, and the amino-terminal fragment of u-PA, containing the EGF-like domain and the kringle module, did not elicit any mitogenic activity. Anti-bFGF antibodies completely suppressed the mitogenic activity of bFGF, but did not have any effect on that of u-PA and t-PA; the activity of both PAs was inhibited by anti-fibronectin IgG concentrations ineffective on bFGF. These results indicate that PAs may be considered growth factors of human fibroblasts. (C) 1994 Academic Press, Inc.
引用
收藏
页码:286 / 294
页数:9
相关论文
共 26 条
[1]  
ANICHINI E, 1994, IN PRESS EXP CELL RE
[2]  
BARLATI S, 1988, CANCER J, V2, P95
[3]   PLASMINOGEN ACTIVATORS IN DEVELOPING PERIPHERAL NERVOUS-SYSTEM, CELLULAR-ORIGIN AND MITOGENIC EFFECT [J].
BARON-VAN EVERCOOREN, A ;
LEPRINCE, P ;
ROGISTER, B ;
LEFEBVRE, PP ;
DELREE, P ;
SELAK, I ;
MOONEN, G .
DEVELOPMENTAL BRAIN RESEARCH, 1987, 36 (01) :101-108
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]   STABILIZATION OF RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH-FACTOR BY CHEMICAL MODIFICATIONS OF CYSTEINE RESIDUES [J].
CACCIA, P ;
NITTI, G ;
CLETINI, O ;
PUCCI, P ;
RUOPPOLO, M ;
BERTOLERO, F ;
VALSASINA, B ;
ROLETTO, F ;
CRISTIANI, C ;
CAUET, G ;
SARMIENTOS, P ;
MALORNI, A ;
MARINO, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02) :649-655
[6]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR, BUT NOT UROKINASE, EXERTS TRANSFORMATION-ENHANCING ACTIVITY [J].
DEPETRO, G ;
VARTIO, T ;
SALONEN, EM ;
VAHERI, A ;
BARLATI, S .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) :563-567
[7]  
DEPETRO G, 1989, CANCER J, V2, P231
[8]   PLASMINOGEN - PURIFICATION FROM HUMAN PLASMA BY AFFINITY CHROMATOGRAPHY [J].
DEUTSCH, DG ;
MERTZ, ET .
SCIENCE, 1970, 170 (3962) :1095-+
[9]   THE MR 17500 REGION OF THE A-CHAIN OF UROKINASE IS REQUIRED FOR INTERACTION WITH A SPECIFIC RECEPTOR IN A431 CELLS [J].
FIBBI, G ;
DINI, G ;
PASQUALI, F ;
PUCCI, M ;
DELROSSO, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 885 (03) :301-308
[10]   2ND-GENERATION PLASMINOGEN ACTIVATORS [J].
HARRIS, TJR .
PROTEIN ENGINEERING, 1987, 1 (06) :449-458